The QualityStocks Daily Monday, August 27th, 2018

Today's Top 3 StockMarketWatch

MarketBeat (AAO:CA) +50.00%

NetworkNewsWire (RGNP) +42.63%

Damn Good Penny Picks (CYLC) +33.58%

The QualityStocks Daily Stock List

Thunder Mountain Gold, Inc. (THMG)

Zacks, FeedBlitz, and MarketWatch reported on Thunder Mountain Gold, Inc. (THMG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Established in 1935, Thunder Mountain Gold, Inc. is a junior gold exploration company. It owns interests in numerous U.S. precious metals projects. The Company’s chief asset is The South Mountain Project. The South Mountain Project is on private and patented land in southern Idaho, just north of the Nevada border. Thunder Mountain Gold has its headquarters in Boise, Idaho. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Another main asset of Thunder Mountain Gold is its Trout Creek Project. This is a grass roots gold target in the Eureka-Battle Mountain trend of central Nevada, now under Joint Exploration Agreement with Newmont USA Limited.

Thunder Mountain Gold owns 100 percent of the South Mountain Mine. This mine has a land package comprising about 1,200 acres of mostly private land - both owned outright and leased. A new gold discovery was revealed in 2009 during fieldwork at South Mountain. The Company’s plan of operation for this, subject to business conditions, is to continue to advance the development at the South Mountain Project.

The Trout Creek target is in the Reese River Valley area south of Battle Mountain, Lander County, Nevada. The target consists of 60 unpatented lode mining claims. Trout Creek is on an important trend with Newmont's Phoenix Mine and the Gold Acres, Pipeline. The Cortez Mine sits to the southeast.

Thunder Mountain Gold signed an Amendment, which modifies and extends the exploration Minerals Lease and Agreement with Newmont USA Limited on Thunder Mountain Gold 's Trout Creek Project. The extension permits it more time to complete work requirements on the project and reduces the yearly work obligations.

The Company’s other projects include Clover Mountain. It controls 40 unpatented lode mining claims, covering approximately 800 acres, near Clover Mountain in Owyhee County, Idaho. Also, its West Tonopah Property consists of 8 unpatented lode mining claims totaling 160 acres in the Tonopah Mining District, Esmeralda County, Nevada.

In April of this year, Thunder Mountain Gold announced that it chose SRK Consulting (U.S.), Inc. to complete the Company's South Mountain Preliminary Economic Analysis (PEA). SRK will help develop data gaps. It will also provide guidance on the continuing resource development work planned to start this field season.

The Study will be equally weighted on the development of a new resource model and an optimized mine plan. SRK provides advice and solutions for clients needing specialized services, primarily in the fields of mining, surface and underground geotechnics, water, waste materials, process engineering, the environment and mineral economics.

The South Mountain Project will remain Thunder Mountain Gold’s focus. However, it also continued the exploration and advancement of the Trout Creek Project in 2015.

Thunder Mountain Gold, Inc. (THMG), closed Monday's trading session at $0.12, up 1.35%, on 158,699 volume with 21 trades. The average volume for the last 60 days is 9,062 and the stock's 52-week low/high is $0.10/$0.30.

chart

Tempus Applied Solutions Holdings, Inc. (TMPS)

MarketWatch and InvestorsHub.com reported on Tempus Applied Solutions Holdings, Inc. (TMPS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Tempus Applied Solutions Holdings, Inc. provides design, engineering, systems integration, and flight operations solutions. These support critical aviation mission requirements for a variety of customers. The Company maintains a highly qualified and skilled in-house engineering team, which supports aircraft modifications, certification, maintenance, as well as flight testing. Tempus Applied Solutions, LLC is the wholly-owned subsidiary of Tempus Applied Solutions Holdings, Inc.  Tempus Applied Solutions has its headquarters in Williamsburg, Virginia.

The Company flies airplanes - fixed wing and rotary, manned or unmanned. It engages in surveillance missions in Africa to flight training in Texas. In addition, Tempus designs and modifies aircraft for special missions, certifies them, and provides turnkey lease and service solutions.

The Company operates Gulfstream, Bombardier, Pilatus, and Cessna aircraft. Most of these aircraft have been specially modified by Tempus for Department of Defense (DoD)-related missions. This includes threat simulation, surveillance, communications relay, and diverse test and development programs.

The Company’s Tempus Applied Solutions subsidiary was awarded FAA (Federal Aviation Administration) approval, in the form of a Supplemental Type Certificate (STC), for Tempus' initial FANS/1-A and ADS-B compliance solution [(Tempus' "Solution AA")]. Tempus' solution has received an "Approved Model List", or AML, STC, which means that it can be applied to any business and commercial aircraft.  FANS and ADS-B compliance will be mandated in most parts of the world by 2020.

Tempus Applied Solutions uses a secure facility with hangar and manufacturing space and secure communications at Brunswick Executive Airport. The facility has two parallel 8000’ x 200’ runways and a 4.5-million-square-foot ramp and taxiways - certified for B-747, A-340, and C-5 aircraft.

The Tempus Design & Engineering Center of Excellence has Designated Engineering Representative (DER) authority from the Federal Aviation Administration (FAA) and the European Aviation Safety Agency (EASA). This center’s specialties include major airframe modifications; interior completions projects; design and materials specifications; modeling and rendering utilizing 3D Max Vision; Supplemental Type Certificates (STC); and Layout of Passenger Accommodations (LOPA) Development.

Recently, Tempus Applied Solutions announced that it was awarded a contract from the United States Air Force (USAF) to provide technical services and flight operations to the USAF Weapons Development and Integration Directorate, (WDID) Platform Integration Function, for aviation systems. Tempus Applied Solutions will integrate the USAF's High-Altitude LIDAR Atmospheric Sensing (HALAS) system into a modified Gulfstream IV aircraft owned by the Company.

This month, Tempus Applied Solutions announced that it entered into a definitive purchase agreement for the acquisition of six Lockheed L-1011s previously owned and operated by the Royal Air Force (RAF) of the United Kingdom (UK).  Four of these aircraft are specifically configured for air-to-air refueling (AAR) operations. The remaining two are configured for passenger and cargo operations only.

These aircraft have numerous years of service life remaining. The L-1011s have been in flyable storage in the UK since their retirement.  The closing of the acquisition will take place following satisfactory inspection of the aircraft and associated log books and support equipment.

Last week, Tempus Applied Solutions reported its first quarterly Operating Profit as part of its financial results for Q2 of 2017 (April 1 – June 30).  The Company delivered more than $300,000, or $0.03 per share (average weighted number of shares), in Operating Profit in comparison to a $1.10 million Loss and negative $0.12 per share from the same period last year. It’s the first Operating Profit since the Initial Public Offering (IPO) in 2015.

Tempus Applied Solutions Holdings, Inc. (TMPS), closed Monday's trading session at $0.0744, up 14.46%, on 1,250 volume with 2 trades. The average volume for the last 60 days is 36,054 and the stock's 52-week low/high is $0.0402/$0.38.

chart

Citius Pharmaceuticals, Inc. (CTXR)

MicroCapDaily, Stock Commander, Penny Stock Prodigy, DSR News, PHUB News, Damn Good Penny Picks, Penny Picks, OTCtipReporter, PennyStockScholar, Profitable Trader Authority, OTCMagic, Penny Stock Newsletter, and PREPUMP STOCKS reported previously on Citius Pharmaceuticals, Inc. (CTXR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products. The Company’s concentration is on anti-infectives, cancer care, and innovative prescription products utilizing unique, patented, or proprietary formulations of earlier approved active pharmaceutical ingredients. Citius Pharmaceuticals is headquartered in Cranford, New Jersey.

The Company is now advancing two proprietary product candidates: the Mino-Lok™ product and a hydrocortisone-lidocaine formulation. The Mino-Lok™ product is advancing to Phase 3 clinical studies. The Mino-Lok™ product is an antibiotic lock solution. It is used to treat patients with catheter-related bloodstream infections (CRBSIs). Mino-Lok™ is under investigation and not approved for commercial use.

Citius Pharmaceuticals is developing a proprietary topical formulation of hydrocortisone (3%) and lidocaine (5%) to provide anti-inflammatory and anesthetic relief to persons suffering from Grade I and II hemorrhoids. The Company has achieved positive results from a Phase 2a study for hydrocortisone-lidocaine formulation for Grade I and II hemorrhoids.

Citius Pharmaceuticals has commenced the pivotal Phase 3 clinical trial Mino-Lok™. This is the above-mentioned antibiotic lock solution used to salvage infected central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs). Mino-Lok™ is undergoing development as an adjunctive therapy for the treatment of catheter-related or central line associated bloodstream infection (CRBSI/CLABSI). Mino-Lok™ together with suitable systemic antibiotic(s), is used to preserve central venous access and to avoid the complications and morbidities associated with catheter removal and reinsertion.

The Company has obtained top line data from a survey of 31 physicians clearly showing a need for catheter salvage in patients with indwelling central venous lines, especially when the catheter is a tunneled or an implanted port. Nineteen Infectious Disease experts and 12 Intensivists surveyed all agreed that salvage would be preferable to catheter exchange, fearing that catheter misplacements, blood clots, or vessel punctures can potentially occur during reinsertion. Most were also concerned that viable venous access may not be available. The survey was conducted by a third party in January of this year.

In March 2017, Citius Pharmaceuticals announced that it concluded negotiations to add South America to its global license for Mino-Lok™. South America was the only territory that was not included in the original sub-license between Novel Anti-Infective Technologies, LLC, an affiliate of MD Anderson Cancer Center (MDACC), and Leonard-Meron Biosciences, Inc. (LMB), a wholly-owned subsidiary of Citius Pharmaceuticals.

Citius Pharmaceuticals, Inc. (CTXR), closed Monday's trading session at $1.46, up 9.77%, on 456,200 volume. The average volume for the last 60 days is 160,263 and the stock's 52-week low/high is $2.55/$16.05.

chart

Bravada Gold Corp. (BGAVF)

Gold Investment Letter, Penny Stock Hub, 4-Traders, NorthernVertex, Stockhouse, Morningstar, Cambridge House International, The Street, Dividend Investor, The Prospector News, and Real Pennies reported on Bravada Gold Corp. (BGAVF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Bravada Gold Corp. is a Nevada-focused exploration and development company. It has a large portfolio of high-quality properties. These properties include a range of development stages. This is from early-stage exploration to advanced-stage exploration and pre-development.  Bravada Gold is based in Vancouver, British Columbia and the Company lists on the OTC Markets Group’s OTCQB.

Bravada Gold retains residual working or royalty interests. The Company explores for precious metals in well-established gold trends in one of the world’s best gold jurisdictions.

At present, five of Bravada’s Nevada properties are being backed by partners. In total this includes earn-in work expenditures of up to $6.5 million and payments to Bravada Gold of up to +$3.0 million in cash and shares. Bravada holds a royalty on eventual barite production on its Shoshone Pediment Project.

Regarding its Wind Mountain project, the Company’s plan is to drill-test for high-grade “Hishikari-type” gold/silver vein mineralization under the existing disseminated resource at Wind Mountain. Pertaining to the SF property, Bravada Gold plans to drill-test for high-grade “Carlin-type” gold mineralization at the property. 

Concerning the North Lone Mountain and South Lone Mountain projects,  plans have not been finalized for Bravada Gold’s two claim groups. However, Nevada Zinc continues to expand the footprint of zinc mineralization on its claims towards Bravada Gold’s South Lone Mountain claims. Should Nevada Zinc complete the purchase of these claims, Bravada will retain a royalty on base and precious metals.

Bravada Gold received earlier this year, subject to posting a reclamation bond, approval of its drilling permit from the U.S. Forest Service for its Quito Gold property. The permit allows four sites to be drilled at the Quito Extension target in 2018. Numerous holes can be drilled from these sites. The Quito Property is situated along the Austin Gold trend in central Nevada.

Bravada Gold, by way of its wholly-owned U.S. subsidiary Bravo Alaska, Inc.,  and Yamana Gold, Inc., through its wholly-owned U.S. subsidiary Meridian Minerals Corp. (collectively Yamana), have agreed to amend the earn-in agreement for the Quito Property.

This amendment will remove a "Claw-back" provision, which allowed Yamana Gold to re-acquire a 51 percent ownership in Quito after earn-in by Bravada Gold of a 70 percent working interest (WI) in the property with all other terms remaining constant. As consideration for the amendment, Yamana Gold receives 1,000,000 common shares in Bravada Gold and warrants to buy 1,000,000 common shares at CDN$0.15 for a period of three years.

Last month, Bravada Gold announced that the earlier announced $480,000 non-brokered private placement has been oversubscribed. The Company will now issue 6,584,000 units in a non-brokered private placement at a price of $0.08 per Unit for gross proceeds of $526,720. Net proceeds from the private placement will be used for property maintenance fees, permitting fees and associated ancillary costs, and accounts payable and for working capital.

Bravada Gold Corp. (BGAVF), closed Monday's trading session at $0.0744, up 6.29%, on 75,000 volume with 4 trades. The average volume for the last 60 days is 38,454 and the stock's 52-week low/high is $0.0524/$0.1699.

chart

Newgioco Group, Inc. (NWGI)

Cantech Letter, Stockhouse, InvestorsHub, TradingView, Simply Wall St, Wallmine, InvestorsHangout, Barchart, The Street, OTC Markets, MarketWatch, last10K, Investor Place, and Wallet Investor reported on Newgioco Group, Inc. (NWGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Newgioco Group, Inc. is a betting software technology business. It provides regulated leisure lottery and gaming products and services through licensed subsidiaries based in Europe. Newgioco Group, together with its wholly-owned subsidiaries, is a fully-licensed and integrated gaming software technology company. Newgioco Group is headquartered in Toronto, Ontario. It also has an office in Rome, Italy. The Company previously went by the name Empire Global Corp. It changed its name to Newgioco Group, Inc. in July 2016.

Newgioco Group has acquired Multigioco Srl, a licensed gaming operator headquartered in Rome. Newgioco’s plan is to aggressively go after attractively priced, fragmented, and profitable gaming operators in Italy. Its goal is to become a top-tier gaming operator over a five-year investment time horizon.

Newgioco also recently announced the signing of two new online operators based in Rome and Sardegna. This expands the Company’s distribution network in western Italy.

Newgioco Group provides its clients an extensive set of leisure gaming products and services. These include sports betting, virtual sports, online casino, poker, bingo, lottery, as well as interactive games and slots. Newgioco Group conducts its business mainly via retail neighborhood betting shops and an internet-based gambling and sports betting software platform under the registered brand Newgioco, by way of its licensed website www.newgioco.it in Italy. Additionally, it offers a unique betting platform (www.odissea.at) providing B2B (Business-to-Business) and B2C (Business-to-Consumer) bet processing.

In February 2018, Newgioco Group announced the launch of NG PAY payment gateway under a licensing agreement with Euronet Worldwide, Inc. (Leawood, Kansas). The Company's secure payment gateway via Euronet will be available on the www.ngpay.it website.

Newgioco Group announced recently the launch of CHATBOT, the Company’s initial phase of Artificial Intelligence (AI) technology incorporated into its unique ELYS betting platform by Odissea. CHATBOT is an innovative AI betting technology employing customized pattern recognition and machine-learning algorithms to determine the relevant features of customer interactions and to develop a total customer betting profile.

Last week, Newgioco Group announced it filed its 2018 Q2 results with the United States Securities and Exchange Commission (SEC). The Company had triple-digit Group performance of almost 190 percent growth in Operating Income. GAAP Revenue rose 118.54 percent to $17.4 million. It was the Company’s fifth consecutive quarterly operating profits.

Newgioco Group, Inc. (NWGI), closed Monday's trading session at $0.46, up 13.86%, on 200 volume with 2 trades. The average volume for the last 60 days is 77,546 and the stock's 52-week low/high is $0.085/$1.78.

chart

Bonterra Resources, Inc. (BONXF)

OTC Markets, HotStocked, Barchart, Business Insider, 4-Traders, Resource World, Investors Hangout, Stockwatch, Streetwise Reports, Stockhouse, InvestorsHub, Mining Feeds, TradingView, and Penny Stock Hub reported on Bonterra Resources, Inc. (BONXF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Bonterra Resources, Inc. is a gold exploration company listed on the OTC Markets Group’s OTCQX. At present, the Company is moving forward with deposit extension and resource expansion in and around its new high-grade Gladiator Gold Deposit. Bonterra’s emphasis is to add ounces to the world class Abitibi Gold Belt in the Provinces of Quebec and Ontario. Bonterra Resources has its head office in Vancouver, British Columbia.

Bonterra is advancing to the completion of an updated NI 43-101 (National Instrument 43-101) Mineral Resource Estimate in the second half of 2018. Its  10,541-hectare Gladiator Gold Project is in the Urban-Barry Greenstone Belt within the Abitibi Subprovince.

The Gladiator Deposit remains open in all directions with drilled dimensions currently outlined to a depth of 1,000 meters with a strike length of 1,200 meters. A minimum of six distinct subparallel zones or mineralized horizons have been identified.

Bonterra Resources announced in July, that further to its news release of May 23, 2018 , it completed and entered into an Option Agreement with Beaufield Resources, Inc. Beaufield has granted Bonterra an option to acquire a 70 percent interest in 81 strategic mineral claims totaling 3,590 hectares, positioned in the Urban Barry Greenstone belt, Quebec, and known as the Duke property.

With this Option Agreement, Bonterra Resources can earn a 70 percent interest in the Property through issuing 4,000,000 common shares to Beaufield Resources upon acceptance of the transaction by the TSX Venture Exchange, paying Beaufield $750,000 in equal amounts over a three-year period, and incurring $4,500,000 in exploration expenditures on the Property over three years.

In addition, the Company has its Larder Lake Gold Project. Larder Lake is 2,165-hectares. It is positioned in eastern Ontario, in McVittie and McGarry Townships, near the town of Virginiatown.

Central to the Larder Lake Gold Property is the Cheminis property (the Cheminis Mine). It includes a vertical shaft to a depth of 1,085 feet, with six levels of which the deepest is at 1,035 feet. Intermittent past production from the Cheminis Mine has totaled about 260,000 tons at a recovered grade of roughly 0.104 ounces Au/ton.

Bonterra Resources recently announced that it received highly positive results for its preliminary metallurgical testwork, which forms part of its continuing Resource Development Program at its 100 percent controlled Gladiator Gold Deposit in Quebec. Results to date show total gold recoveries of up to 99.4 percent. This includes 76.1 percent from the Gravity circuit.

Head assay results from the metallurgical testing ranged from 8.0 g/t Au to 10.0 g/t Au. They showed first-rate grade reconciliation with initial drill hole assays.

Last month, Bonterra Resources announced the latest drilling results from the continuing Resource Development Program at the Gladiator Gold Deposit. This includes an intersection of 15.3 g/t Au over 2.7 m, extending the Footwall Zone down-plunge to the east. Recent drilling results extended mineralization along numerous zones and continues to demonstrate the continuity of the high-grade gold mineralization at depth and along strike at the Gladiator Deposit.

Also in July, Bonterra Resources and Metanor Resources, Inc. announced that, further to their news release dated June 18, 2018, the two companies entered into a definitive arrangement agreement dated July 20, 2018, to combine Bonterra Resources and Metanor Resources to establish a new advanced Canadian gold exploration and development company centered on becoming the leader in the building out and future mining development of the Urban Barry Quebec Gold Camp.

Bonterra Resources, Inc. (BONXF), closed Monday's trading session at $0.2481, down 3.01%, on 123,677 volume with 40 trades. The average volume for the last 60 days is 78,118 and the stock's 52-week low/high is $0.228/$0.5746.

chart

Sayona Mining Limited (DMNXF)

OilandGas 360, The Street, Barchart, Your Drilling News, CentralCharts, OTC Markets, Penny Stock Hub, WalletInvestor, HotCopper, Metals News, Investors Hangout, Penny Stock Tweets, 4-Traders, Stockwatch, MarketWatch, Stockhouse, Capital Equity Review, InvestorsHub, and Predict Wall Street reported on Sayona Mining Limited (DMNXF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Sayona Mining Limited, together with its subsidiaries, engages in the identification, acquisition, evaluation, and exploration of mineral assets in Australia and globally. The Company chiefly explores for lithium and graphite. It formerly went by the name DiamonEx Limited. It changed its corporate name to Sayona Mining Limited in May 2013. Listed on the OTC Markets, Sayona Mining is based in Paddington, Australia.

Sayona Mining’s focus is on sourcing and developing the raw materials required to make lithium-ion batteries. The Company’s primary emphasis is the development of the advanced stage Authier Lithium Project in Quebec. The Authier Project is 45 kilometers northwest of the city of Val d’Or, a major mining service center in Quebec. Authier mineralization is hosted in a spodumene-bearing pegmatite intrusion with more than 18,000 meters of drilling in 139 holes.

The Authier Lithium Project has advanced, near term development potential. It has a Pre-Feasibility Study (PFS) demonstrating technical and economic viability. The Project area comprises 19 mineral claims totaling 653 hectares. It extends 3.4 kilometers in an east-west, and 3.1 kilometers in a north-south direction, respectively. The location of the Mineral claims is over Crown Land. Sayona Mining completed greater than 8,000 meters of drilling during 2016 and 2017.

The Authier Lithium Project is amenable to simple open-cut mining and processing methods. The project is in close proximity to development infrastructure. In July 2016, Sayona acquired 100 percent of the Authier project for CAD$4 million. In addition, the Company controls a portfolio of lithium and graphite exploration projects in Western Australia.

Concerning Western Australia, Sayona Mining has 17 tenements in the Pilbara Region, covering a total area of 1918km2. Of these, nine were acquired by way of a deal with Great Sandy, with the Mallina Project – E47/2983, being the flagship project.

The East Kimberley Graphite Project is Sayona’s strategic entry into the graphite market. In 2015, the Company announced a strategic entry into the large flake graphite market through securing a large ground position in the East Kimberley area of Western Australia. The Kimberley region is a proven province for high purity, large flake graphite.

The East Kimberley project is 240 kilometers south of Wyndham Port and 220 kilometers south-south-west of the regional center, Kununurra. The Project includes one granted tenement and three separate tenement applications. The Project covers 278 km2. It comprises two areas, Keller and Corkwood. Sayona Mining has 100 percent of the graphite interests across four tenements in the East Kimberley, following the completion of two option-to-purchase agreements.

This past June, Sayona Mining reported the start of a testing program to produce lithium carbonate and lithium hydroxide from the Authier pilot plant lithium concentrate. The Company recently completed a pilot plant program that processed five tons of Authier drill core into greater than 400 kilograms of spodumene concentrate.

This program demonstrated that a 6 percent Li2O concentrate could be produced at a metallurgical recovery of 79 percent. SGS Canada, Inc. will perform the downstream testing program.

Sayona Mining Limited (DMNXF), closed Monday's trading session at $0.03, up 7.14%, on 10,000 volume with 1 trade. The average volume for the last 60 days is 204,046 and the stock's 52-week low/high is $0.005/$0.10.

chart

Alternate Health Corp. (AHGIF)

InvestorsHub, The Street, Daily Marijuana Observer, WalletInvestor, Weed Newswire, MicroCapFinder, OTC Insider, MarketWatch, GuruFocus, CannabisFN, OTC Markets, and Marijuana Index reported on Alternate Health Corp. (AHGIF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Alternate Health Corp. is a global medical cannabis company listed on the OTCQB. It provides software solutions for the medical cannabis industry. The Company employs best in class technology, research, education, production, and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices. Alternate Health is based in San Antonio, Texas.

The Company is a diversified healthcare investment and Holdings Company. It operates via a network of subsidiaries that share proprietary, highly secure cloud-based software solutions to boost efficiencies and protect patient data.

Its companies are: Alternate Health Clinics; Alternate Health Labs; Alternate Medical Media; Alternate RX; CanaPass; and VIP-Patient. Alternate Health has operations in Venice, California; San Antonio, Texas; and Toronto, Ontario.

Alternate Health announced on May 10, 2018, that its Management received Board of Directors approval to explore a spinoff plan for the Company's non-cannabis assets. The estimation is that this will take a minimum of three to four months to complete the due diligence process. 

The Company develops software applications and processing systems for the medical industry utilizing proprietary technology platforms (VIP-Patient & CanaPass systems) to assist doctors in their practice management and patients with their need for first-rate medical care. Alternate Health’s services include practice management and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the emerging medical cannabis industry.

Alternate Health announced this past April the transformation of the CanaPass Patient Management system to a complete Ethereum-based blockchain Electronic Medical Records (EMR)/Electronic Health Records (HER) system.

Moreover, the Company announced at the beginning of May a proposed plan that it believes will substantially increase shareholder value via a spinoff of its blockchain payment systems, Alternate Health Labs subsidiary, and other non-cannabis assets, into a new corporation that will apply to be listed on a major U.S. exchange.

Alternate Health has taken a leadership position in blockchain financial and healthcare solutions. A key product is its Zi App Blockchain Payment Gateway. It was designed originally to enable digital payments in cannabis. However, the system has earned considerable interest as a payment solution for even larger markets, including multi-level marketing, commercial leases, as well as equipment rentals.

Earlier this month, Alternate Health announced that it signed a binding contract on August 6, 2018, to provide laboratory services for a large multistate laboratory provider. The Company expected to start testing samples this month. It is targeting a ramp up to a monthly sample rate of 25,000 - 30,000 by December 2018.

Alternate Health Corp. (AHGIF), closed Monday's trading session at $0.3967, down 2.03%, on 100 volume with 1 trade. The average volume for the last 60 days is 22,808 and the stock's 52-week low/high is $0.316/$2.60.

chart

BioLargo, Inc. (BLGO)

Tiny Gems, Stock News Now, Promotion Stock Secrets, SECFilings, FeedBlitz, Equities, TopPennyStockMovers, SmallCapVoice, and Penny Sleuth reported previously on BioLargo, Inc. (BLGO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

BioLargo, Inc. delivers practical solutions for clean water, clean air, and advanced wound care. It delivers technology-based products, which help solve some of the globe’s most important problems that threaten water, food, agriculture, healthcare and energy. BioLargo is an innovator of sustainable science and technology and a full-service environmental engineering company. BioLargo has its corporate office in Westminster, California. The Company’s shares trade on the OTCQB. 

BioLargo’s subsidiary is BioLargo Water, Inc.  BioLargo Water showcases the Advanced Oxidation Systems, including its AOS Filter. This product in development is purposely designed to eliminate common, troublesome, and toxic contaminants in water in a fraction of the time and expense of present technologies.

The BioLargo® AOS Filter is the Company’s featured AOS Filter system. The BioLargo® AOS Filter extends the life of filtration systems, reduces corrosion, and conserves chemistry. The Company’s Canadian subsidiary, BioLargo Water, Inc. started a prototype development project for its AOS Filter technology.

The BioLargo® AOS Filter facilitates ongoing and scalable treatment with maximum efficiency using GRAS components to convert contaminates to H2O and CO2.  It destroys hard to get contaminates and disinfects quickly and completely. The BioLargo® AOS Filter is complementary with manifold filter systems.

BioLargo’s subsidiary, Odor-No-More, Inc., features award-winning products serving the pet, equine, military supply, and consumer markets. This includes the Nature's Best Solution® and Deodorall® brands. CupriDyne® Clean Industrial Odor Eliminator is made by Odor-No-More.  Odor-No-More has signed what are known as national purchasing or national supply agreements with three leading U.S. waste handling enterprises.

BioLargo’s subsidiary, Clyra Medical Technologies, Inc., concentrates on advanced wound care management. Furthermore, BioLargo owns a 50 percent interest in the Isan System. This system was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project, now under license to Clarion Water, Inc.

Last week,  BioLargo announced that the Innovative Conservation Program (ICP) granted funding to support a pre-commercial pilot water treatment study project at the Joshua Tree Brewery. This brewery is under construction in Joshua Tree, California, and scheduled to open in late 2018.

This pilot project will feature BioLargo’s Advanced Oxidation System (AOS) and Aquacycl’s BioElectrochemical Treatment Technology (BETT™) to demonstrate that these combined technologies can provide effective and cost-efficient treatment of the brewery’s wastewater to meet California discharge standards and avoid regulatory non-compliance. The project’s objective is to allow the wastewater to be used for landscaping irrigation.

BioLargo, Inc. (BLGO), closed Monday's trading session at $0.261, down 0.42%, on 107,807 volume with 36 trades. The average volume for the last 60 days is 141,930 and the stock's 52-week low/high is $0.204/$0.56.

chart

RegeneRx Biopharmaceuticals, Inc. (RGRX)

Stock News Now, TopPennyStockMovers, PennyStockProphet, Penny Pick Finders, Planet Penny Stocks, Buzz Stocks, Stock Onion, and SmarTrend Newsletters reported previously on RegeneRx Biopharmaceuticals, Inc. (RGRX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company. It concentrates on tissue protection, repair, and regeneration with a comprehensive portfolio of product candidates for first-in-class therapeutic peptides. The Company’s mission is to research and develop novel pharmaceuticals that protect and repair tissue and organ damage caused by disease, trauma, or other pathology. RegeneRx Biopharmaceuticals is based in Rockville, Maryland. 

RegeneRx holds numerous issued patents or filed patent applications internationally to enable and protect multiple indications and applications for its product candidates. Currently, the Company has three drug candidates in clinical development for ophthalmic, cardiac, and dermal indications. In addition, it has three active strategic licensing agreements in the United States, China, and Pan Asia (Korea, Japan, and Australia, among others). RegeneRx also has patents and patent applications covering its products in many nations worldwide. 

The Company is focusing on moving three distinct Tβ4-based drug candidates through the clinic. These are RGN-137, RGN-259, and RGN-352. RGN-137 is a topical gel formulation of the peptide Tβ4. RegeneRx is developing this as a novel treatment to hasten dermal healing. RGN-137 is a Tβ4-based dermal gel formulation undergoing development for epidermolysis bullosa, which is a rare skin condition.

RegeneRx is also developing RGN-352. RGN-352 is its TB4-based injectable. This is a Phase 2-ready drug candidate designed to be administered systemically to prevent and repair cardiac damage resulting from heart attacks and central nervous system tissue damage associated disorders. These include peripheral neuropathy, multiple sclerosis and traumatic brain injuries - including stroke.

RegeneRx Biopharmaceuticals is centering on the development of Thymosin beta 4 (a novel therapeutic peptide), for tissue and organ protection, repair and regeneration. RGN-259, its TB4-based ophthalmic drug candidate, has been designated an orphan drug for the treatment of neurotrophic keratopathy (NK), which is a main emphasis of the Company's clinical development efforts in the U.S.

This past July, RegeneRx, via its U.S joint venture (JV), ReGenTree LLC, completed patient enrolment and treatment in its second Phase 3 clinical trial in around approximately 600 patients with dry eye syndrome.  Additionally, the Company is at the same conducting a 46-patient Phase 3 clinical trial in patients with NK, targeted for completion in 2018. Also, RGN-259 is undergoing development in patients with dry eye syndrome in Asia by way of RegeneRx's two Asian partnerships.  

At the end of August, RegeneRx Biopharmaceuticals announced it completed a license expansion agreement with GtreeBNT for the rights to RGN-137, RegeneRx's topical gel formulation of thymosin beta 4 (Tβ4), in Europe, South Korea, Japan, Canada, and Australia.

Earlier this month, RegeneRx announced that the U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance for Thymosin beta 4 (Tβ4) for use in the treatment of dry eye syndrome.  Tβ4 is the active pharmaceutical ingredient in RegeneRx's proprietary drug candidate, RGN-259. This is a first-in-class product candidate designed for topical administration to patients suffering from dry eye syndrome.

RegeneRx Biopharmaceuticals, Inc. (RGRX), closed Monday's trading session at $0.19, up 4.28%, on 108,500 volume with 9 trades. The average volume for the last 60 days is 39,421 and the stock's 52-week low/high is $0.139/$0.38.

chart

Provision Holding, Inc. (PVHO)

GrowthPennyStocks, Penny Stock General, Shiznit Stocks, HotStockProfits, PennyDoctor, Stock Beast, RedChip, PennyStockLocks.com, Epic Stock Picks, Equity Observer, Value Penny Stocks, Wolf of Penny Stocks, Small Cap Firm, OTCMagic, MicroCapDaily, and StockRockandRoll reported on Provision Holding, Inc. (PVHO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Provision Holding, Inc., by way of its subsidiary, focuses on the development and distribution of intelligent interactive three-dimensional (3D) holographic display technologies, software, and integrated solutions for consumer and commercial centered application. These are chiefly for advertising and product merchandising markets. The Company’s initial line of display systems has proven to be ideally suited for indoor and outdoor point-of-sale (PoS), merchandising, and PoS related advertising venues. Provision Interactive Technologies, Inc. is a subsidiary of Provision Holding. Provision Holding is based in Chatsworth, California. 

Provision’s products include HoloVision displays and 3D Savings Center kiosks. These enable advertisers and customers to reach captive audiences in grocery stores, malls, convenience stores, gas stations, banks, as well as other retail sites. The Company’s proprietary 3D holographic display technologies give advertisers first-rate ability to direct customized content to a target audience. 

Provision's 3D holographic display systems represent a unique technology. This technology provides the projection of full color, high-resolution videos into space detached from the screen, without any special glasses. The Company has completed the development and prototype of its latest 3D holographic display system, the HL50.

The HL50 is its largest Holovision™ product. The design of it is for exhibitions and special events.  The HL50 uses Provision Interactive Technologies’ patented and award-winning 3D holographic technology.  It comes complete. This includes a media player and the Company’s proprietary software, HoloSoft™.  The HL50 can project visually stunning 3D holographic videos, detached from the screen, floating in space more than 40 inches outward.

This past June, Provision Interactive Technologies announced that the Company entered into a multi-year partnership agreement with Discount Drug Mart, Inc. This partnership agreement is to install Provision’s proprietary 3D Savings Center kiosks inside Discount Drug Mart stores. The agreement represents the next major retail partnership for Provision.

Prosperity Investments, under its Joyful ATM brand, has entered into an agreement with Provision Interactive Technologies to integrate its 3D holographic display and coupon redemption platform into Joyful ATMs to boost in-store engagement and purchases at point-of-sale (PoS).

Greater than 48,000 Joyful ATM units are planned to undergo deployment across the U.S. and in another 68 countries over the next 72 months, at locations including banks, retailers, convenience stores, gas stations, and government buildings. Via the partnership, the ATMs will project 3D holographic advertising messages to attract customers to the unit. Upon the customer approaching the unit, they can redeem coupons for the advertised products that can be used right away, driving enhanced PoS activity.

Provision Holding, Inc. (PVHO), closed Monday's trading session at $0.01, up 9.89%, on 3,023,452 volume with 34 trades. The average volume for the last 60 days is 1,012,730 and the stock's 52-week low/high is $0.0082/$0.069.

chart

Stem Holdings, Inc. (STMH)

Market Screener, Jet Life Penny Stocks, Dividend Investor, InvestorsHub, OTC Markets, Wallet Investor, MarketWatch, Barchart, 4-Traders, Stockhouse, Simply Wall St, last10k, Morningstar, TradingView, YCharts, Midas Letter, Stockopedia, InvestorsHangout, and GuruFocus reported on Stem Holdings, Inc. (STMH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Stem Holdings, Inc. develops strategic brands for contemporary cannabis consumers. The Company builds and partners with companies in numerous sectors of the marijuana market from distribution to hemp cultivation. Stem buys, improves, and leases properties for use in the cannabis production, distribution, and sales industry in Oregon. OTCQB-listed the Company is headquartered in Boca Raton, Florida.

Stem brands and partnerships consist of Incredibles; Reefer Distribution Co.; Supernatural; Cannavore, and PUL. The Company’s brands and partnerships also include TJ’s Gardens; GreenTFarms; Travis x James; Dose-Ology; G Pen, and Craft Extracts.

Regarding Stem Retail Properties, the Company builds boutique retail stores. TJ’s Provisions is its flagship marijuana dispensary, situated in Eugene, Oregon, ten minutes from the downtown. Stem also has its TJ’s on Willamette marijuana dispensary approximately one mile from the University of Oregon campus.

In addition, the Company has its TJ's on Powell. This is a 2,000 square foot retail storefront in Portland, Oregon. TJ’s on Powell has a prime south-facing position on a busy highway route.

Regarding Stem’s Cultivation & Processing Properties, the Company has its 42nd Street facility. This large warehouse serves as a first-class indoor cultivation facility just outside of Eugene, Oregon. This property has 22 grow rooms.

The Company also has its Mulino Farm greenhouse cultivation facility. The property in Clackamas County has 12 commercial-grade greenhouses. Additionally, Stem has its Applegate Farms cultivation facility. It consists of 40 acres in Jacksonville, Oregon. Output at Scale is 2,000 lbs annually.

Moreover, the Company has its TJ’s Wallis. This Eugene property will include two facilities. They will provide space for cultivation and processing. This location has a premier commercial kitchen for edibles production and grow rooms and an extraction lab.

Furthermore, Stem’s TJ’s Las Vegas property outside of Vegas will allow cultivation, processing, and distribution operations for the fast-growing Nevada cannabis market. This property is 5,450 square feet.

Stem Holdings, Inc. (STMH), closed Monday's trading session at $3.20, down 5.88%, on 1,650 volume with 8 trades. The average volume for the last 60 days is 2,161 and the stock's 52-week low/high is $3.40/$7.75.

chart

The QualityStocks Company Corner

Sugarmade, Inc. (OTC: SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (OTC: SGMD) was featured today in an article from NetworkNewsWire describing why the company is “One to Watch.” Also today, the company was highlighted in an article from MarketNewsUpdate explaining how the shifting legal landscape in the legal cannabis market continues to provide incredible opportunities for a growing number public companies.

Sugarmade, Inc. (OTCQB: SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.1599, off by 9.86%, on 6,472,829 volume with 875 trades. The average volume for the last 60 days is 704,880 and the stock's 52-week low/high is $0.0219/$0.43.

Recent News

chart

QMC Quantum Minerals Corp. (TSX-V: QMC) (FSE: 3LQ) (OTC: QMCQF)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is presently preparing to bring the Irgon Lithium Mine Project online for production, which is much faster than expected due to work previously done. To view the full article, visit: http://nnw.fm/UWl7V.

QMC Quantum Minerals Corp. (TSX-V: QMC) (FSE: 3LQ) (OTC: QMCQF) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.265, up 9.23%, on 32,543 volume with 24 trades. The average volume for the last 60 days is 107,806 and the stock's 52-week low/high is $0.078/$1.46.

Recent News

chart

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF)

The QualityStocks Daily Newsletter would like to spotlight Koios Beverage Corp. (SNOVF).

Koios Beverage Corp. (CSE:KBEV) (OTC:SNOVF) (the "Company" or "Koios"), is pleased to announce it has entered into a co-packaging agreement with Golden Global Goods, the parent company of Rocky Mountain Soda.  

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) develops and distributes nature-based products that boost brain function, enhance health, and improve productivity. Its core vision is to help a billion people worldwide live more productively through the development of nootropics, which are supplements that improve cognitive abilities.

The company’s flagship product, Koios, is a GMP-certified dietary supplement. Made from natural ingredients and backed by science, Koios is designed to improve focus, memory, mental drive, clarity and energy. The company produces Koios in the following formulations:

  • Powder supplements containing nootropics as well as caffeine and lion’s mane and chaga mushrooms;
  • Vegan-friendly capsules;
  • Canned beverages containing nootropics along with MCT oil to burn fat and increase metabolism.

Not to be mistaken with prescription-only drugs which are at times used for similar effects, nootropics are over-the-counter dietary supplements; some of which, like Koios, contain ingredients that are currently used in the treatment of patients with Alzheimer’s disease. The global field of nootropics is growing rapidly and expected to reach USD $6,059.4 Mn by 2024 with a CAGR of 17.9 percent from 2016 to 2024.

According to media reports, there is believed to be significant and growing use of nootropics among high-achieving students and professionals. The UK’s leading Guardian newspaper found that nootropics are commonly used in Silicon Valley by computer industry professionals who want to “hack” their minds and maximize their productivity without any possible negative effects on the brain.

Koios was born out of the personal struggles of its founder and CEO, Chris Miller, who has ADHD. Miller found that the symptoms of his condition held him back when navigating the competitive modern workplace. Unhappy with the effects of the Adderall he was prescribed, Chris began a search for a natural remedy that would improve his attention and mental capacity.

Speaking of his struggles at this time, Miller says, “Coffee and energy drinks were no longer helping me. Eventually, I was drinking so much caffeine that I was beginning to notice negative and troubling health effects.” He adds, “I believed there had to be a better way. Better technology that the earth was providing that I could implement and not only boost my daily performance but take care of my brain and body long-term.” After years of experiments and with the help of leading scientists, he developed Koios, named after the Greek Titan who represented rational intelligence.

Koios contains the following ingredients, among others:

  • Vitamin B12: Crucial for the function of the nervous system and the synthesis of DNA, B12 also helps in the creation of red blood cells.
  • Vitamin B6: This vitamin is crucial for brain development among children and brain function in adults. B6 is also important in the production of key hormones: serotonin, which regulates mood, norepinephrine, which helps us handle stress, and dopamine.
  • Huperzine A: Developed from the Chinese club moss plant, huperzine A is used on Alzheimer’s patients to boost their memories. It is also used to raise energy levels and alertness and is the subject of medical trials to test its efficacy when combined with other drugs.
  • Bacopa: Also known as brahmi, bacopa is an Indian herb used in Ayurvedic medicine to improve concentration and memory. Modern science has recognized its effectiveness, and it is used to treat symptoms caused by Alzheimer’s disease, ADHD and anxiety.
  • Ciwujia: Sports scientists have been interested in this herb since they heard of how mountain climbers in Tibet use it to boost their performance at high altitudes. Peer-reviewed research has shown that Ciwujia has clear positive effects on endurance.

A full breakdown of Koios’ active ingredients is available on the company website.

Additionally, safety is paramount for Koios, with all its products developed in a high-grade nutraceutical laboratory which is GMP-certified and in compliance with FDA guidelines. Koios only uses high-quality ingredients sourced from the best possible locations in order to deliver a product that is not only safe but also “one of the world’s greatest nootropic blends.”

The company’s products can be found online and in stores, both across the United States and internationally, via a continuously growing distribution network.

Koios CEO Chris Miller is supported by a team with strong credentials in medical supplement start-ups, corporate finance and sales, which includes CFO/Director Anthony Jackson, Director Scott Walters, Director Konstantine Lichtenwald and Vice President of Sales Gina Burrus.

With people seeking a mental edge and cognitive boost, Koios believes that there is an opening in the market for its nature-based, over-the-counter nootropics, especially when current prescription medicines have worrying side effects..

Koios Beverage Corp. (KBEV), closed the day's trading session at $0.21, up 5.00%, on 538,800 volume. The stock's 52-week low/high is $0.17/$0.53.

Recent News

chart

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Sunniva (CSE: SNN) (OTCQX: SNNVF) stands out among the emerging largest compliant producers with a vertically integrated business model and commitment to delivering safe, consistent, high-quality products and services. To view the full article, visit: http://cnw.fm/9tB6J.

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $5.34, up 4.50%, on 110,928 volume with 258 trades. The average volume for the last 60 days is 47,480 and the stock's 52-week low/high is $3.61/$16.00.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

NetworkNewsAudio announces the Audio Press Release (APR) titled "Perfect Storm Brewing for North American Coffee Market," featuring Youngevity International, Inc. (NASDAQ: YGYI). To hear the NetworkNewsAudio version, visit: http://nnw.fm/BZ0Ht. To view the full editorial, visit http://nnw.fm/ylN7I.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $4.21, up 3.44%, on 63,065 volume with 205 trades. The average volume for the last 60 days is 15,621 and the stock's 52-week low/high is $3.1674/$6.75.

Recent News

chart

DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

DPW Holdings, Inc. (NYSE American: DPW) (the “Company”) a diversified holding company, announced management will present at the 20th Annual Rodman & Renshaw Global Investment Conference sponsored by H.C. Wainwright & Co. The event is being held on September 4-6, 2018 at the St. Regis New York Hotel in New York City.

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.416, up 2.41%, on 849,556 volume with 1,509 trades. The average volume for the last 60 days is 1,903,970 and the stock's 52-week low/high is $0.389/$5.95.

Recent News

chart

Zenergy Brands, Inc. (OTC: ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy Brands (OTC: ZNGY), through its Zero Cost Program™, enables companies to upgrade older, inefficient energy infrastructure by combining energy services and smart controls with no upfront costs. To view the full article, visit: http://nnw.fm/VK6Nl.

Zenergy Brands, Inc. (OTC: ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0007, even for the day, on 6,618,248 volume with 16 trades. The average volume for the last 60 days is 21,706,910 and the stock's 52-week low/high is $0.0005/$0.03.

Recent News

chart

CytoDyn Inc. (OTCQB: CYDY)

The QualityStocks Daily Newsletter would like to spotlight CytoDyn Inc. (CYDY).

CytoDyn, Inc. (OTCQB:CYDY), (the “Company”) announced President and CEO Nader Pourhassan’s interview on Uptick Newswire’s “Stock Day” Podcast.

CytoDyn Inc. (OTCQB: CYDY) is a biotechnology company focused on the clinical development and potential commercialization of a new class of HIV/AIDS therapeutics or viral-entry inhibitors intended to protect healthy cells from viral infection. The company’s pipeline includes its lead product, PRO 140 for multiple indications among which are human immunodeficiency virus (HIV), graft-versus-host disease (GvHD), colon cancer, and multiple sclerosis (MS), each in various stages of development. CytoDyn first approval is focused on HIV indications for two different HIV populations.

PRO 140 is a humanized monoclonal antibody directed at CCR5, a molecular portal that HIV uses to enter T-cells. PRO 140 works by blocking the predominant HIV (R5) subtype entry into T-cells by masking this required co-receptor, CCR5.

CytoDyn has completed one pivotal phase 3 clinical trials of PRO 140 use in combination with current drugs for population that has limited treatment options. PRO 140 is also currently in another phase 3 (investigative trial) for a second approval for another HIV population. HIV continues to be a major global public health issue. There is no cure for the disease that has claimed more than 35 million lives to date, according to the World Health Organization (“WHO”). In 2017, 940,000 people around the world died from HIV-related causes. There were approximately 36.9 million people living with HIV at the end of 2017 with 1.8 million people becoming newly infected during that same year. The WHO estimates there were 21.7 million people globally receiving antiretroviral therapy (“ART”) in 2017.

HIV targets the immune system and weakens the body’s defense systems against infections and some types of cancer. As the virus destroys and impairs the function of immune cells, infected individuals gradually become immunodeficient which results in increased susceptibility to a wide range of infections, cancers and other diseases that people with healthy immune systems can fight off. The most advanced stage of HIV infection is Acquired Immunodeficiency Syndrome (AIDS), which can take from 2 to 15 years to develop depending on the individual.

PRO 140 functions by blocking the HIV co-receptor CCR5, a molecular portal HIV uses to enter T-cells, thus preventing the HIV virus from entering the cell. CCR5 is a protein located on the surface of white blood cells that normally serves as a receptor for chemicals that attract immune cells to the site of inflammation. Clinical trials to date indicate PRO 140 does not interfere with these normal CCR5 functions. Results from phase 1 and phase 2 human clinical trials have shown PRO 140 significantly reduces viral burden in people infected with HIV. Importantly, in a recent phase 2b clinical trial, PRO 140 demonstrated it can allow a subset of R5 strain of HIV population to replace their current HIV regimen (Highly Active Antiretroviral Therapy or “HAART.”) by a simple sub-cutaneous self-injectable dose of PRO 140 which is administered once a week. Some of those patients have received PRO 140 as their only therapy for almost four years.

The PRO 140 antibody appears to be a powerful antiviral agent with hardly any side effects, toxicity. More than 500 patients have used PRO 140 in clinical trial and no resistance has ever been developed in any patients including patients in monotherapy of PRO 140 for almost four years.

PRO 140, which is taken as an easy-to-use, weekly, subcutaneous self-administered dose, has almost no side effects or toxicity with no report of any serious adverse event related to PRO 140 in more than 500 patients in eight different clinical trial.

As we indicated earlier patients given PRO 140 showed no drug resistance on monotherapy for some almost four years while 76% of HAART patients developed a resistance to some portion of the lifetime drug regimen. Patient compliance with HAART is also the main reason why only 35% of HIV patients in US reporting complete viral load (VL) suppression which is VL<50 cp/mL.

In addition to its research into the powerful potential of PRO 140 for use in HIV patients, CytoDyn is pursuing PRO 140 as a therapeutic anti-viral agent in other non-HIV indications that could benefit from PRO 140’s ability to block CCR5. These immunologic indications include new reactions to cancer, transplantation rejection, autoimmune diseases and chronic inflammation such as Multiple Sclerosis. The company sees the significant potential for multiple pipeline opportunities for PRO 140.

The U.S. Food and Drug Administration has designated PRO 140 as a “fast track” product for HIV and granted Orphan Drug Designation to it for the prevention of GvHD in transplant patients. CytoDyn has initiated its first clinical trial with PRO 140 in an immunological indication for GvHD in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation. The company is also investigating PRO 140 in animal models of cancer progression and autoimmunity with positive results and has published its animal study results in GvHD in peer-reviewed journal.

CytoDyn president and CEO Nader Z. Pourhassan, Ph.D. joined the company in 2008 and is credited for purchasing PRO 140 from Progenics in 2012 and has taken a new path to approval for the product. He is the co-inventor of monotherapy path for PRO 140. He has taken PRO 140 development from phase 2 to Completed successful phase 3 in about four years. He now has more than 10 years of drug development experience and has overseen the rapid clinical development of PRO 140 as a therapy for HIV into two phase 3 for two different indications. He also initiated PRO 140 first immunological indication in GvHD (currently in phase 2). He is also involved in preclinical and clinical development of PRO 140 in additional immunological indications.?Dr. Pourhassan, who has more than 20 years of business development experience, has led CytoDyn’s capital market activities since joining the company in 2008. He received his Bachelor of Science from Utah State University, Master of Science from Brigham Young University, and his Ph.D. in Mechanical Engineering from the University of Utah and is the author of three books.

CytoDyn Inc. (CYDY), closed the day's trading session at $0.55, up 3.36%, on 232,787 volume with 75 trades. The average volume for the last 60 days is 330,854 and the stock's 52-week low/high is $0.40/$0.836.

Recent News

chart

Pacific Software, Inc. (OTC: PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software, Inc. (OTC: PFSF), an emerging development technology corporation and master licensor of Hyperledger blockchain-based systems, was recently featured in an interview by NewEconomies.com (http://nnw.fm/OwKJ8).

Pacific Software, Inc. (OTC: PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture, cannabis, and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

Agriculture
For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Cannabis
Perceiving blockchain as an ideal mechanism for the complexities of the cannabis industry, Pacific Software will strive to improve the transparency, compliance, and efficiency of the “seed-to-sale” supply chain in states where the plant is legal.

Controlled Substances
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $5.25, even for the day. The average volume for the last 60 days is 63 and the stock's 52-week low/high is $4.00/$5.25.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF), a premium food and beverage company, is preparing to launch its OKI brand of premium CBD products to consumers during the third quarter of 2018. To view the full article, visit: http://nnw.fm/e1MLa.

Headquartered in Vancouver, Canada, with operations offices in southern California, Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is a premium food and beverage company that develops CBD-infused functional foods, beverages and supplements poised for global distribution. All products in the Phivida label are infused with organic, hemp-derived cannabinoids into a variety of premium foods, beverages and clinical products for everyday health. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s motto – “Celebrating Health and Wellness, in Harmony™” – underscores Phivida’s mission to lead the alternative health care sector as the benchmark standard in premium CBD-infused functional beverages and tinctures. To execute this goal, Phivida is taking advantage of positive legislative developments in the United States and has defined an elevated national route-to-market strategy across the U.S. where small regional distributors will be now be replaced with large national distributors.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who as Phivida’s chief commercial officer is tasked with driving new sales revenue growth.

Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF), the company’s strong balance sheet carries CAD$15.7 million with no debt or loans with less than 60 million shares outstanding and the company is now well-capitalized to fun major mainstream distribution with a solid structure poised for long-term growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every product for microbials, heavy metals, pesticides, residual solvents, terpenes, and potency to guarantee less than 0.3 percent THC (tetrahydrocannabinol, the chemical compound in cannabis responsible for a euphoric high) is present.

Regulations

Federally legal under the 2014 Farm Bill, CBD from Hemp Oil is a rapid growth market across the USA. When derived from marijuana, CBD remains a schedule one controlled substances, giving hemp derived CBD oil infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the USA Industrial Hemp laws to an agricultural commodity status and effectively removed hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the US CBD-Hemp sector. In February 2018, the Supreme Court preceded over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp, and the legality of industrial hemp. In the final ruling the Supreme Court unequivocally determined that – when produced domestically under the Farm Bill – hemp (and its derivatives) are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA) giving the Farm Bill primary jurisdiction over the governance of the CBD-Hemp Oil industry in the USA.

The DEA further conceded it does not “seek to control cannabinoids,” and that only marijuana derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g. US Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreation cannabis – with edibles to be added in 2019. The bill will officially become law as of October 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

3 Wholly Owned Subsidiaries

  • Phivida Organics Inc. offers professional-grade, wholesale, whole plant hemp oil extracts made from 100-percent certified organic hemp stalk. Phivida’s hemp oil extracts are CO2-extracted under quality assurance/clinical standards and are third-party lab tested to assure only pharmaceutical grade, cGMP certified, full-spectrum products are produced and available for sale. Phivida Organics produces hemp oil extracts that deliver nano-encapsulated cannabinoids in water soluble formulations designed to be absorbed up to 10 times faster than other oils, providing up to 400 percent bioavailability. Phivida Hemp Oil Vida+ extract products are available now online at www.Phivida.com.
  • Phivida Nutrition blends the best of nature into CBD-infused lifestyle branded beverages including a variety of CBD infused iced teas and CBD infused flavored waters.
  • Phivida Enhanced – Under the VIDA brand, CBD-infused tinctures, capsules and other supplement products are distributed to alternative health care clinics across the USA.

WeedMD-Phivida

Phivida has signed a binding letter of intent to joint venture WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on cannabis-infused beverages. The new joint-venture company, Cannabis Beverages Inc. (“CanBev”), plans to develop a production facility at WeedMD’s state-of-the-art greenhouse facility in Strathroy, Ontario, Canada. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distribution of cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets.

Management from both WeedMD and Phivida are collaborating on design and engineering strategies and site evaluations on a 610,000-square-foot, state-of-the art facility in Strathroy for the development of CanBev. As an emerging certified food grade production plant, the Strathroy facility is an ideal location and comes is equipped with extensive production infrastructure, including 50,000 sq. ft. of food production and packaging area, cold storage, loading docks, and adequate space to expand for future growth.

Strategic Agreements

Phivida Organics has also entered into an agreement to carry out a pharmacokinetic (PK) study on its hemp-derived, nanoencapsulated CBD with Artelo Biosciences Inc. at the University of Nottingham, School of Medicine at the Royal Derby Hospital, England. The study will test encapsulated-CBD on healthy volunteers and measure how fast and how much CBD enters the blood stream after oral consumption with each of the different formulations developed by Phivida Organics.

Phivida has also activated distribution agreements with Asayake Inc. to become one of the first federally approved CBD-infused food and supplement brands in Japan. With first mover status achieved, Phivida now markets to an underserved, yet highly informed population of 127 million patients and practitioners. The supplement market in Japan is estimated at US$10 billion with the overall functional foods market at US$21 billion. The Asia-Pacific region is the fastest growing market for natural plant-based supplements. Phivida now plans to prepare a formal application to Japan’s Consumer Affairs Agency to register the company’s CBD-infused functional food and beverage products for approval under the country’s Food with Functional Claims regime. The functional beverage market in Japan is estimated at US$10.35 billion with a CAGR of 2.5 percent (2015-2025).

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.6267, off by 1.24%, on 154,442 volume with 75 trades. The average volume for the last 60 days is 33,942 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

Sharing Services, Inc. (OTC: SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Utah’s state tourism office has gained international attention through its Life Elevated brand, and that identifying slogan could easily apply to the rising star of Sharing Services, Inc. (OTC: SHRV), as well. The Texas-based holdings company aims to help people find improved quality of life through the variety of products and services that its direct selling representatives offer.

Sharing Services, Inc. (OTC: SHRV), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders –  Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.301, off by 2.11%, on 31,646 volume with 12 trades. The average volume for the last 60 days is 18,782 and the stock's 52-week low/high is $0.125/$0.92.

Recent News

chart

SinglePoint, Inc. (OTCQB: SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (OTCQB: SING), a technology and investment company specializing in the acquisition of small to mid-sized companies, announced in a press release (http://nnw.fm/K1P9b) its status as a fully reporting company by way of filing Form 10-12G. At the same time, the company reported a significant increase of nearly 100 percent in second quarter revenues, as compared to the same quarter of 2017.

SinglePoint, Inc. (OTCQB: SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.03105, off by 1.40%, on 5,203,127 volume with 286 trades. The average volume for the last 60 days is 6,150,571 and the stock's 52-week low/high is $0.0235/$0.133.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.